SureTrader SureTrader
Home > Boards > US Listed > Medical - Drugs >

PRA Health Sciences, Inc. (PRAH)

Add PRAH Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 10/8/2016 1:06:58 PM - Followers: 0 - Board type: Free - Posts Today: 0
PRA Health Sciences, Inc.

4130 ParkLake Avenue
Suite 400
Raleigh, NC 27612
United States

PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development services to the biotechnology and pharmaceutical industries worldwide. The company offers integrated services, such as data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. Its services include a suite of product registration services, such as clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. The company’s services also comprise strategic solutions, including embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services, including Phase I through Phase IIa clinical trials and bioanalytical laboratory services. It conducts clinical trials in the areas of pharmaceutical development, comprising oncology, central nervous system, inflammation, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. The company was founded in 1976 and is headquartered in Raleigh, North Carolina. PRA Health Sciences, Inc. is a subsidiary of KKR PRA Investors L.P.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
PRAH News: PRA Health Sciences to Report Third Quarter 2016 Earnings 10/10/2016 03:47:02 PM
PRAH News: Takeda and PRA Health Sciences Announce Transformational Clinical Development and Marketed Product Partnership 09/12/2016 09:00:00 AM
PRAH News: Takeda et PRA Health Sciences annoncent un partenariat de développement clinique transformationnel et de produits commercial... 09/12/2016 09:00:00 AM
PRAH News: Takeda und PRA Health Sciences geben Partnerschaft für transformierende klinische Entwicklung und vermarktete Produkte bekannt 09/12/2016 09:00:00 AM
PRAH News: Statement of Changes in Beneficial Ownership (4) 08/22/2016 05:37:39 PM
#1   PRAH bullish 57.20 stocktrademan 10/08/16 01:06:58 PM